People infected with Hiv may advantage from micronutrient supplementation, agreeing to a report published in the February 2007, issue of the American Journal of Clinical Nutrition. The main focus of this report was with Hiv-infected persons not receiving extremely active antiretroviral therapy (Haart), but also reports that added study of those receiving Haart may show benefits as well because Haart therapy is shown to deplete many micronutrients in the body.
Hiv medications are relatively easy to fetch in developed countries, but only 1 in 7 in Asian countries and 1 in 10 in African countries have passage to Hiv antiviral drugs. Micronutrient deficiencies are commonly observed in those with developed Hiv disease and are linked with higher risk of disease progression and mortality. In those receiving Haart, immunologic function is restored but these drugs do not eliminate weight loss and wasting. Because of these factors, micronutrient supplementation can be an uncostly way to improve capability of life and possibly sell out condition care expenditures in those suffering from developed stages of Hiv disease as well as those who continue to suffer from disease effects not treated by Haart therapy.
Hiv Antiretroviral Drugs
In one placebo-controlled study, Hiv-infected patients were given Vitamins A, C, and E for six months. At the beginning of the test, all patients had lower levels of these foremost nutrients when compared to a group of Hiv-negative salutary volunteers. At the end of the study, the levels of these nutrients were general in the patients given supplementation and not in the placebo group. The study also showed that the supplemented group had substantially best antioxidant defenses and lower levels of oxidative stress than the placebo group.
Because Hiv medications have a direct result on the synthesis and metabolism of micronutrients in the body, restoring these depleted levels through dietary supplementation may also provide grand advantage for those on Haart therapy. A small study showed that greater intake of Vitamin E in adults receiving Haart reduced the outcome of Haart-related complications which include body fat redistribution, dyslipidemia and insulin resistance. Other studies have been shown to stimulate glutathione peroxidase action and discount of oxidative stress.
Such studies demonstrate the valuable need for optimal nutritional preserve in Hiv-infected people. It also calls for the need of added studies to provide added validation and solutions for citizen not able to receive Haart therapy as well as to preserve and improve the allinclusive condition of those who are on Haart therapy. The long-term benefits may be seen in reduced condition care expenditures, colse to the world, as well as improved capability of life for those suffering from the effects of Hiv infection.
Can Micronutrient Supplementation heighten the health of Hiv Patients?See Also : hiv antiretroviral drugs
0 comments: